Results 221 to 230 of about 147,146 (257)
Some of the next articles are maybe not open access.
Nonischemic cardiomyopathy with reduced ejection fraction secondary to hyperthyroidism
JAAPA, 2021ABSTRACT Dilated cardiomyopathy is a form of heart failure characterized by left ventricular dilation with impaired systolic function. Causes may include ischemic heart disease, hypertensive heart disease, valvular heart disease, endocrine disorders, substance use, and viral diseases.
Melanie M, Martin, Megan R, Collins
openaire +2 more sources
New pharmacotherapy for heart failure with reduced ejection fraction
Expert Review of Cardiovascular Therapy, 2020The European Society of Cardiology (ESC), Canadian Cardiovascular Society, and the American College of Cardiology Heart Failure (HF) guidelines all currently recommend the use of Angiotensin Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARBs) and Beta Blockers (BB) in the treatment of HF with a reduced ejection fraction (HFrEF ...
Sara Sotirakos +3 more
openaire +2 more sources
blockers for heart failure with reduced ejection fraction
BMJ, 2011#### Case scenario A 74 year old man attends the surgery for review of his longstanding heart failure. He has an exercise tolerance of just a few yards, limited by breathlessness. His jugular venous pressure is not raised, he has no ankle oedema, and the lung bases are clear. There is no evidence of fluid overload.
Derek G, Waller, James R, Waller
openaire +2 more sources
Heart failure with mildly reduced ejection fraction
2023Abstract The 2016 European Society of Cardiology (ESC) Heart Failure Guidelines introduced heart failure with mildly reduced ejection fraction (HFmrEF) as a separate category of patients. These patients have a left ventricular ejection fraction (LVEF) of between 40% and 50%.
Adriaan A Voors +3 more
openaire +1 more source
Heart Failure with Reduced Ejection Fraction
2019Heart failure with reduced ejection fraction (HF-REF) is a common problem worldwide and its prevalence rises with age. It is associated with substantial morbidity and mortality. Development of the condition is driven by a number of haemodynamic and neurohumoral pathophysiological processes which, in turn, lead to adverse remodelling of the myocardium ...
Alice M. Jackson, Pardeep S. Jhund
openaire +1 more source
Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology, 2021Clyde W. Yancy +2 more
openaire +2 more sources
Heart Failure with Reduced Ejection Fraction
Heart Failure Clinics, 2023Terri L. Allison, Beth Towery Davidson
openaire +3 more sources
Heart and Vessels, 2014
Although there have been several studies regarding heart failure with preserved ejection fraction (HFpEF), investigations of the risk factors for readmission of Japanese patients with HFpEF remain scarce. Therefore, our goal was to identify the risk factors for readmission of Japanese patients with heart failure (HF), particularly those with HFpEF.
Masahiko, Setoguchi +4 more
openaire +2 more sources
Although there have been several studies regarding heart failure with preserved ejection fraction (HFpEF), investigations of the risk factors for readmission of Japanese patients with HFpEF remain scarce. Therefore, our goal was to identify the risk factors for readmission of Japanese patients with heart failure (HF), particularly those with HFpEF.
Masahiko, Setoguchi +4 more
openaire +2 more sources
Heart Failure with Reduced Ejection Fraction
2022Prashant Rao, Marwa A. Sabe
openaire +2 more sources